Radius Health: Pioneering New Therapies for Women’s Bone Health

Radius Health is a biopharmaceutical company dedicated to revolutionizing the treatment of women’s bone health. With a focus on developing innovative therapies for osteoporosis and other bone-related conditions, Radius Health is at the forefront of advancing medical science to improve the lives of millions of women worldwide.

One of the most significant achievements of Radius Health is the development of TYMLOS® (abaloparatide), a first-in-class treatment for postmenopausal women with osteoporosis at high risk for fracture. TYMLOS® has been shown to increase bone mineral density and reduce the risk of fractures, providing patients with a new and effective option for managing their condition. In addition to TYMLOS®, Radius Health is also working on other novel treatments for women’s bone health, including investigational therapies for osteoarthritis and hypoparathyroidism.

Through cutting-edge research and a commitment to excellence, Radius Health is paving the way for a brighter future for women with bone health issues. By partnering with healthcare providers, researchers, and patients, Radius Health is able to identify unmet needs in the field of women’s health and develop targeted therapies to address these challenges. With a pipeline of promising treatments in development, Radius Health is poised to make a lasting impact on the lives of women around the world.